AMN Healthcare Services, Inc. (AMN) 2024 Q2 法說會逐字稿

完整原文

使用警語:中文譯文來源為 AI 翻譯,僅供參考,實際內容請以英文原文為主

  • Operator

    Operator

  • Good day, and thank you for standing by. Welcome to the AMN Healthcare second quarter 2024 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded

    大家好,感謝您稍候。歡迎參加 AMN Healthcare 2024 年第二季財報電話會議。(接線員指示) 請注意,今天的會議將被錄音。

  • I would now like to turn the call over to Randle Reece, Senior Director of Investor Relations. Please go ahead, Randy.

    現在我想把電話交給投資人關係資深總監 Randle Reece。Randy,請開始。

  • Randle Reece - Investor Relations

    Randle Reece - Investor Relations

  • Good afternoon, everyone. Welcome to AMN Healthcare's second quarter 2024 earnings call. A replay of this webcast will be available at ir.amnhealthcare.com at the conclusion of this call. Remarks we make during this call about future expectations, projections, trends, plans, events, or circumstances constitute forward-looking statements.

    各位下午好。歡迎參加 AMN Healthcare 2024 年第二季財報電話會議。本次網路直播的重播將於本次電話會議結束後,於 ir.amnhealthcare.com 提供。我們在本次電話會議中就未來預期、預測、趨勢、計畫、事件或情況所作的評論,均構成前瞻性陳述。

  • These statements reflect the company's current beliefs based upon information currently available to it. Our actual results may differ materially from those indicated by these forward-looking statements because of various factors and cautionary statements, including those identified in our most recently filed forms 10-K and 10-Q.

    這些陳述反映公司基於目前可得資訊所持有的當前信念。由於各種因素及警示性陳述(包括我們最近提交的 10-K 與 10-Q 表格中所識別者),我們的實際結果可能與這些前瞻性陳述所示有重大差異。

  • Our earnings release and subsequent filings with the SEC. The company does not intend to update guidance, or any forward-looking statements provided today prior to its next earnings release. This call contains certain non-GAAP financial information.

    以及我們的財報新聞稿與其後向美國證券交易委員會(SEC)提交的文件。公司無意在下一次財報發布前更新指引或今日提供的任何前瞻性陳述。本次電話會議包含若干非 GAAP 財務資訊。

  • Information regarding and reconciliations of these non-GAAP measures to the most directly comparable GAAP measures are included in our earnings release and on our financial reports page at ir.amnhealthcare.com. On the call today are Cary Grace, President and Chief Executive Officer; and Jeff Knudson, Chief Financial Officer.

    關於這些非 GAAP 指標的資訊,以及其與最直接可比的 GAAP 指標之調節表,已包含於我們的財報新聞稿中,並刊載於 ir.amnhealthcare.com 的財務報告頁面。

  • I will now turn the call over to Cary.

    現在我將把電話交給 Cary。

  • Cary Grace - President, Chief Executive Officer, Director

    Cary Grace - President, Chief Executive Officer, Director

  • Thank you for joining us for a review of our latest financial results and updated outlook against some continued challenging market conditions, we made progress on stabilizing our performance. Demand for healthcare was impressive this quarter and the market for skilled caregivers shows signs of improvement.

    感謝各位加入我們,一同回顧最新財務結果與更新後的展望。在市場環境仍具挑戰的情況下,我們在穩定營運表現方面取得進展。本季醫療照護需求表現亮眼,而熟練照護人員的市場也顯示改善跡象。

  • Patient demand and labor supply are crucial drivers of long-term growth in our businesses. Our consolidated revenue for the second quarter was $741 million, which enabled us to produce $16 million in net income, $100 million operating cash flow, and adjusted EBITDA of $94 million.

    病患需求與勞動供給是我們各項業務長期成長的關鍵驅動因素。第二季合併營收為 7.41 億美元,使我們得以創造 1,600 萬美元淨利、1 億美元營運現金流,以及 9,400 萬美元調整後 EBITDA。

  • The adjusted EBITDA margin for the quarter surpassed the high end of guidance. Excluding some discrete items that favorably impacted SG&A, adjusted EBITDA margin would have been above the high end of our guidance range. While we continue to see some pressure on placement, volume, and revenue from larger clients, we expect our third quarter adjusted EBITDA margin to be higher than sell-side analyst expectations.

    本季調整後 EBITDA 利潤率超越指引區間上緣。若排除若干對 SG&A 產生有利影響的一次性項目,調整後 EBITDA 利潤率仍將高於我們指引區間上緣。儘管我們仍看到來自大型客戶在派遣(placement)、量(volume)與營收方面的壓力,我們預期第三季調整後 EBITDA 利潤率將高於賣方分析師的預期。

  • Our third quarter outlook at the midpoint implies that adjusted EBITDA and adjusted EPS would be in line with expectations though our revenue outlook is approximately 4% below consensus. AMN continues to improve how well we are aligned with all segments of the market for total talent solutions in healthcare.

    我們第三季展望以中位數來看,意味著調整後 EBITDA 與調整後 EPS 將符合預期,但我們的營收展望約較市場共識低 4%。AMN 持續改善我們與醫療照護整體人才解決方案市場各細分領域的契合度。

  • These efforts are vitally important to our long-term success. Coming off 2023, when we were in a net loss position with MSP contracts year-to-date, we are net neutral with wins and losses with last year's RFP behind us, and we are better situated with our clients today.

    這些努力對我們的長期成功至關重要。在 2023 年結束後,我們在 MSP 合約方面年初至今處於淨流失狀態;隨著去年 RFP 已告一段落,我們目前在贏單與失單上呈現淨持平,且如今與客戶的合作基礎更為穩固。

  • The diversification of our business portfolio, including several high-margin, technology-enabled revenue streams, has enabled AMN to maintain profit margins at attractive levels. At the same time, we are delivering to our staffing customers pricing and value that are in line with our industry peers.

    我們業務組合的多元化(包括多項高毛利、科技賦能的營收來源),使 AMN 得以將利潤率維持在具吸引力的水準。同時,我們也向人力派遣客戶提供與同業相當的定價與價值。

  • Across our staffing markets, we are working toward capturing our share of large opportunities in VMS, vendor-neutral, third-party and direct staffing, where we again made progress this quarter. With our technology investments and rollout, brand consolidation and reorganization of the way we go to market and deliver, AMN effectively has been re-platforming most of the company.

    在各個派遣市場中,我們正致力於掌握 VMS、供應商中立(vendor-neutral)、第三方以及直聘派遣等大型機會的市占,本季我們再次取得進展。透過我們的科技投資與推廣、品牌整併,以及市場拓展與交付方式的重整,AMN 實際上正在對公司大部分業務進行平台重建(re-platforming)。

  • ShiftWise Flex is now managing more than half of our ShiftWise vendor-neutral spend under management. We also began deploying ShiftWise Flex for our master vendor MSP clients earlier this quarter. We have a competitive platform that opens opportunities for us in current and new markets.

    ShiftWise Flex 目前已管理我們 ShiftWise 供應商中立(vendor-neutral)受管支出(spend under management)的一半以上。本季稍早,我們也開始為主供應商(master vendor)MSP 客戶部署 ShiftWise Flex。我們擁有具競爭力的平台,為我們在現有與新市場開啟機會。

  • This was demonstrated recently when ShiftWise Flex was awarded a multi-year public sector contract, beating out a competitive list of healthcare and technology industry rivals. We have seen a healthy increase in the VMS pipeline both in terms of spend under management and the number of deals.

    近期 ShiftWise Flex 獲頒一項多年期公共部門合約,擊敗一系列具競爭力的醫療照護與科技產業對手,便證明了這一點。我們看到 VMS 商機管線在受管支出規模與交易數量兩方面皆有健康成長。

  • Our market Insights tool is now being used by some of our largest clients and will be part of our ShiftWise Flex platform. This powerful tool provides clients with market intelligence to help inform them on market trends and how to set up bill rates to attract healthcare professionals by specialty, geographic area and by times of the year.

    我們的 Market Insights 工具目前已被部分最大客戶使用,並將成為 ShiftWise Flex 平台的一部分。這項強大的工具可為客戶提供市場情報,協助其掌握市場趨勢,並依專科、地理區域及一年中的不同時段設定帳單費率(bill rates),以吸引醫療專業人員。

  • We are rolling out innovative workforce solutions leveraging our clinician app AMN Passport, including internal float pool, internal agency, and shift-level management. We have deployed these solutions to help some MSP clients and have an active implementation pipeline.

    我們正利用臨床人員 App「AMN Passport」推出創新的人力解決方案,包括內部浮動人力池(internal float pool)、內部派遣機構(internal agency)以及班次層級管理(shift-level management)。我們已部署這些解決方案以協助部分 MSP 客戶,並有一條活躍的導入管線。

  • We expect that our internal progress will improve our ability to serve clients, win new business, and gain market share. Meanwhile, the AMN team continues to deliver on our client's current needs to help them build a high-quality, sustainable workforce. Let's review our second quarter performance in detail.

    我們預期內部進展將提升我們服務客戶、贏得新業務並擴大市占的能力。同時,AMN 團隊持續滿足客戶當前需求,協助其建立高品質且可持續的人力結構。接下來讓我們詳細回顧第二季表現。

  • In the second quarter, nurse and allied solutions recorded revenue of [$442 million] in line with our expectations across our travel, nurse, and allied businesses volume, bill rates, and average hours were consistent with our assumptions entering the quarter. Gross margin for the segment was lower than the first quarter, primarily because of a favorable worker's comp adjustment in the prior quarter.

    第二季,護理與醫技(nurse and allied)解決方案營收為 [4.42 億美元],符合我們的預期;在旅遊護理(travel)、護理與醫技業務方面,量、帳單費率(bill rates)與平均工時均與我們在進入本季時的假設一致。該部門毛利率低於第一季,主要因前一季有一項有利的勞工補償(worker's comp)調整。

  • We offset the gross margin movement by reducing expenses and controlling costs. Our third quarter outlook for nurse and allied revenue is down approximately 32% to 34% year-over-year, better than the first half comparison, but still lower quarter-over-quarter. Demand as measured by open orders has been on upward trend since April.

    我們透過降低費用並控管成本,抵銷了毛利率的變動。我們對第三季護理與醫技營收的展望為年減約 32% 至 34%,較上半年比較基期更佳,但仍較前一季下滑。以未結訂單(open orders)衡量的需求自 4 月以來呈上升趨勢。

  • Total nurse and allied orders grew nearly 20% since the beginning of the second quarter, with the strongest growth in travel nurse. Though this increase was less than past normal seasonality, it was much improved over last year. At the same time, we continue to see large clients reduce the utilization of contingent labor amid strong permanent hiring and reduced employee attrition.

    自第二季開始以來,護理與醫技總訂單成長近 20%,其中以旅遊護理成長最為強勁。儘管此增幅低於以往的正常季節性水準,但相較去年已大幅改善。同時,在強勁的永久聘僱(permanent hiring)與員工離職率下降的背景下,我們仍看到大型客戶降低對臨時人力(contingent labor)的使用。

  • Labor market data show that permanent job growth for hospitals in the first half of 2024 was the strongest since 1982. Taking into account all these factors, we see scenarios in which nurse and allied revenue, excluding international, could range from being modestly down to modestly higher in Q4 from Q3.

    勞動市場數據顯示,2024 年上半年醫院永久職缺的就業成長為自 1982 年以來最強。綜合考量上述因素,我們看到多種情境:若排除國際業務,護理與醫技營收在第四季相較第三季可能小幅下滑,也可能小幅成長。

  • Visibility for nurse and allied beyond the current quarter has been challenging since the beginning of 2023. We expect to receive winter needs orders later in Q3, which will give us more visibility into Q4 trends.

    自 2023 年初以來,護理與醫技業務在當季之後的能見度一直具有挑戰。我們預期將在第三季較後期收到冬季需求訂單,這將使我們對第四季趨勢有更高的能見度。

  • Our physician and leadership solutions segment had second quarter revenue of $186 million, up 6% year-over-year and about 4% lower than we had expected. The organic locum tenens business was up 1% quarter-over-quarter, although down 11% year-over-year. We saw extensions fall off in the quarter as clients were focused on cost management and were slower to make hiring decisions.

    我們的醫師與領導力解決方案事業部第二季營收為1.86億美元,年增6%,且較我們原先預期低約4%。有機的臨時代班醫師(locum tenens)業務較上季成長1%,但較去年同期下滑11%。本季我們看到續約(延長派遣)減少,因客戶專注於成本管理,且在做出招募決策上更為遲緩。

  • These factors impacted our organic locum's business as well as MSDR. Demand in locums is healthy and coupled with our technology investments to improve our speed to fill as well as MSDR's capabilities, we are excited about our growth potential in this important market.

    這些因素影響了我們的有機臨時代班醫師業務以及MSDR。臨時代班醫師需求仍然健康,加上我們在技術上的投資以提升補缺速度,以及MSDR的能力,我們對於在這個重要市場的成長潛力感到振奮。

  • Results for interim leadership in the search were flat versus the first quarter though demand remains inconsistent. Segment gross margin in the quarter was lower than the first quarter due to a lower bill pay spread in locum tenants. This was offset largely by prudent expense management.

    搜尋業務中的臨時領導職務(interim leadership)結果與第一季相比持平,儘管需求仍不穩定。本季事業部毛利率低於第一季,原因是臨時代班醫師業務的帳單與薪酬價差(bill-pay spread)較低。這在很大程度上被審慎的費用管理所抵銷。

  • For the third quarter, we expect physician and leadership solutions revenue to be up 12% to 14% year over year. In the technology and workforce solutions segment, second quarter revenue was $112 million lower by 11% year-over-year and in line with our expectations. Language services posted 18% revenue growth driven by strong utilization of video interpretation. All other solutions in the segment were consistent with our outlook.

    展望第三季,我們預期醫師與領導力解決方案營收將較去年同期成長12%至14%。在科技與人力解決方案(TWS)事業部,第二季營收為1.12億美元,年減11%,符合我們的預期。語言服務營收成長18%,主要由視訊口譯的強勁使用率所帶動。該事業部其他所有解決方案皆符合我們的展望。

  • The TWS segment contributed $47 million of operating income, more than 40% of total segment operating income this quarter. The TWS segment profit margin also improved substantially this quarter. Our long-term strategy is to continue increasing the segment share of our revenue and earnings due to its alignment with client's desires for more tech-enabled solutions and its attractive growth and margin profile.

    TWS事業部本季貢獻4,700萬美元的營業利益,占本季各事業部營業利益總額的40%以上。TWS事業部的利潤率本季也大幅改善。我們的長期策略是持續提高該事業部在營收與獲利中的占比,因其符合客戶對更多科技賦能解決方案的需求,且具備具吸引力的成長與利潤率特性。

  • For the third quarter, we project technology and workforce solutions revenue to be down 10% to 12% from the prior year. We have carefully managed long-term strategy and near-term spending in an improving environment still having its crosscurrents. This has made it especially important for AMN to ensure that our perspective of the changing healthcare sector is as clear and current as possible.

    展望第三季,我們預估科技與人力解決方案營收將較去年同期下滑10%至12%。在環境改善但仍存在多重交互影響因素(crosscurrents)的情況下,我們已審慎管理長期策略與短期支出。這也使得AMN特別需要確保我們對於變動中的醫療照護產業之觀點盡可能清晰且即時。

  • We were delighted to add Jim Hinton to our Board of Directors. Jim has invaluable experience as former CEO of outstanding health systems Baylor, Scott and White and Presbyterian Health Services New Mexico. In addition to serving as a pass Board Chair of the American Hospital association.

    我們很高興邀請Jim Hinton加入董事會。Jim擁有無可取代的經驗,曾任卓越醫療體系Baylor、Scott and White以及新墨西哥州Presbyterian Health Services的前執行長。此外,他也曾擔任美國醫院協會(American Hospital Association)前任董事會主席。

  • We also recently launched our first Executive Advisory Board to help guide the company's mission of providing innovative, total talent solutions for healthcare. Our Executive Advisory Board will ensure that AMN is closely aligned with the current and future needs of healthcare organizations as they deal with rising demand and increasingly complex labor supply.

    我們近期也成立了首個高階主管諮詢委員會(Executive Advisory Board),以協助引導公司使命:為醫療照護提供創新、全方位的人才解決方案。我們的高階主管諮詢委員會將確保AMN與醫療機構在面對需求上升與勞動供給日益複雜時的當前與未來需求緊密對齊。

  • At the helm of our Executive Advisory Board is Mike Butler, who was President of Providence and led the health system through extraordinary growth. Before I turn the call over to Jeff for a financial review, I want to recognize the wonderful AMN team and our healthcare professionals for their impressive efforts serving our communities and all our stakeholders.

    我們高階主管諮詢委員會由Mike Butler領軍,他曾任Providence總裁,並帶領該醫療體系實現非凡成長。在我把電話會議交給Jeff進行財務回顧之前,我想表揚優秀的AMN團隊與我們的醫療專業人員,他們為服務社區與所有利害關係人所付出的卓越努力令人印象深刻。

  • Your mission and your excellence are what enables AMN's ability to have such a positive impact in serving the healthcare needs of our communities.

    你們的使命感與卓越表現,正是讓AMN能在滿足社區醫療照護需求方面產生如此正面影響的關鍵。

  • Now Jeff will continue with a review of our quarterly results and outlook.

    接下來由Jeff繼續回顧我們的季度業績與展望。

  • Jeffrey Knudson - Chief Financial Officer, Treasurer

    Jeffrey Knudson - Chief Financial Officer, Treasurer

  • Thank you, Cary, and good afternoon, everyone. Second quarter consolidated revenues were $741 million, down 25% from the second quarter of 2023 and down 10% sequentially in line with expectations. The sequential decrease was primarily due to lower volume in the Nurse and Allied segment and the locum tenens and VMS businesses.

    謝謝你,Cary,各位下午好。第二季合併營收為7.41億美元,較2023年第二季下滑25%,較上季下滑10%,符合預期。較上季下滑主要是因護理與醫事專業(Nurse and Allied)事業部,以及臨時代班醫師(locum tenens)與VMS業務量較低。

  • Consolidated gross margin for the second quarter was 31%, also in line with expectations year over year gross margin decreased 230 basis points, driven mainly by lower margins across all three segments, partly offset by a favorable segment mix. Sequentially, gross margin decreased 40 basis points, primarily due to lower Nurse and Allied segment and locums gross margin, partially offset by a favorable revenue mix shift.

    第二季合併毛利率為31%,亦符合預期;與去年同期相比,毛利率下降230個基點,主要由三個事業部毛利率普遍較低所致,部分被較有利的事業部組合所抵銷。與上季相比,毛利率下降40個基點,主要因護理與醫事專業事業部及臨時代班醫師毛利率較低,部分被較有利的營收組合轉移所抵銷。

  • Consolidated SG&A expenses were $149 million or 20.1% of revenue compared with $202 million or 20.4% of revenue in the prior year period at $175 million or 21.3% of revenue in the previous quarter.

    第二季合併銷售、一般及管理費用(SG&A)為1.49億美元,占營收20.1%;相較之下,去年同期為2.02億美元,占營收20.4%,上一季為1.75億美元,占營收21.3%。

  • The decrease in SG&A expenses year over year was primarily due to lower employee and professional service expenses as we remain steadfast in reducing cost to match the revenues, lower employee expenses and favorable actuarial adjustments for professional liability insurance drove the decrease sequentially.

    SG&A費用年減主要因員工與專業服務費用較低;我們持續堅定地降低成本以匹配營收。較上季的下降則由員工費用降低以及專業責任保險的精算調整有利影響所帶動。

  • Adjusted SG&A, which excludes acquisition integration and other costs, legal settlement accrual changes and stock-based compensation expense was $137 million in the second quarter or 18.5% of revenue, impairment of $170 million, our 17.1% of revenue in the prior year period and $162 million or 19.7% of revenue in the previous quarter.

    調整後SG&A(不含併購整合及其他成本、法律和解準備金變動,以及股份基礎給付費用)第二季為1.37億美元,占營收18.5%;相較之下,去年同期為1.70億美元,占營收17.1%,上一季為1.62億美元,占營收19.7%。

  • Discrete items that we do not expect to recur in the third quarter included an actuarial adjustment for professional liability insurance and a change in the accrual for incentive compensation. These items reduced SG&A by $7 million in the quarter. Nurse and Allied revenue was $442 million in the second quarter, down 36% from the second quarter of 2023.

    我們預期第三季不會再發生的單次項目包括:專業責任保險的精算調整,以及獎勵性薪酬準備金的變動。這些項目使本季SG&A減少700萬美元。護理與醫事專業第二季營收為4.42億美元,較2023年第二季下滑36%。

  • Sequentially, segment revenue was down 15%, driven by lower volume and lower rates and Travel Nurse and Allied average fill rate was down 12% year over year and 3% sequentially, influenced by mix shift toward our year-over-year volume decreased 24% and average hours worked were 1% lower sequentially. Volume was down 11%, while the average hours worked for flat.

    與上季相比,該事業部營收下滑15%,主要由量減與費率下降所致;旅行護理與醫事專業(Travel Nurse and Allied)平均填補率(average fill rate)年減12%、季減3%,並受到組合轉向我們的影響;年比量下滑24%,平均工時較上季下降1%。量下滑11%,而平均工時則持平。

  • Travel Nurse revenue in the second quarter was $277 million, a decrease of 42% from the prior year period and 17% from the prior quarter. Allied revenue in the quarter was $151 million, down 17% year over year and 11% sequentially. Nurse and Allied gross margin in the second quarter was 23.8%, a decrease of 290 basis points year over year, primarily due to increases in housing, travel and allowance expenses and the deleveraging impact of lower bill rates.

    第二季旅行護理營收為2.77億美元,較去年同期下降42%,較上一季下降17%。本季醫事專業(Allied)營收為1.51億美元,年減17%,季減11%。護理與醫事專業第二季毛利率為23.8%,年減290個基點,主要因住房、差旅與津貼費用增加,以及帳單費率下降造成的槓桿效應不利(deleveraging)。

  • Sequentially, gross margin decreased 130 basis points, mainly due to workers' comp accrual adjustments that benefited the first quarter margin along with higher housing costs. Segment operating margin of 10.4% decreased 450 basis points year over year, but increased 10 basis points sequentially. The slight increase from the first quarter was driven primarily by favorable insurance actuarial adjustments and lower employee expenses, offsetting the lower gross margin.

    與上季相比,毛利率下降130個基點,主要因第一季受惠的勞工補償準備金調整(workers' comp accrual adjustments)在本季不再有利,以及住房成本較高。事業部營業利益率為10.4%,年減450個基點,但季增10個基點。相較第一季的小幅上升主要由有利的保險精算調整與員工費用降低所帶動,抵銷了較低的毛利率。

  • Moving to the Physician and Leadership Solutions segment. Second quarter revenue of $186 million increased 6% year over year due to the MSDR acquisition. Sequentially, revenue was down 1% driven by lower locum tenens revenue and lower volume in the search business as expected.

    接著談醫師與領導力解決方案事業部。第二季營收1.86億美元,年增6%,主要因收購MSDR所致。與上季相比,營收下降1%,如預期主要由臨時代班醫師營收較低以及搜尋業務量較低所驅動。

  • Locum tenens revenue in the quarter was $143 million, up 17% year over year with the growth coming from the MSDR acquisition in our leadership, revenue of $30 million decreased 17% from the prior year period and was flat sequentially. Search revenue of $13 million was down 27% year over year and down 1% sequentially as volumes remain low.

    本季臨時代班(locum tenens)營收為1.43億美元,年增17%,成長主要來自MSDR收購;而我們的領導力業務營收為3,000萬美元,較去年同期下降17%,且與前一季持平。搜尋業務營收為1,300萬美元,年減27%,季減1%,因為量能仍然偏低。

  • Gross margin for the Physician Leadership Solutions segment was 30.5%, down 460 basis points year over year and 110 basis points sequentially. The year over year decline was primarily attributable to a lower bill pay spread within locum tenens, partially offset by improved gross margin in the insurance business.

    醫師領導力解決方案(Physician Leadership Solutions)部門的毛利率為30.5%,年減460個基點,季減110個基點。年對年下滑主要歸因於臨時代班(locum tenens)業務中的帳款支付利差(bill pay spread)較低,部分被保險業務毛利率改善所抵銷。

  • Segment operating margin was 11.6%, which decreased 340 basis points year over year, primarily due to lower gross margin. Sequentially, operating margin decreased 20 basis points.

    部門營業利益率為11.6%,年減340個基點,主要因毛利率較低。就季比而言,營業利益率下降20個基點。

  • Technology and Workforce Solutions revenue for the second quarter was $112 million, down 11% year over year as the revenue decrease in the VMS business more than offset the language services revenue growth. Sequentially, revenue was flat. Language Services revenue for the quarter was $75 million, an increase of 18% year over year and 5% sequentially.

    第二季科技與人力解決方案(Technology and Workforce Solutions)營收為1.12億美元,年減11%,因VMS業務營收下滑的影響超過語言服務營收成長。季比營收持平。本季語言服務營收為7,500萬美元,年增18%,季增5%。

  • VMS revenue for the quarter was $28 million, a decrease of 41% year over year and 5% sequentially. Segment gross margin was 60.2%, down from 66.7% in the prior year period, primarily due to lower revenue within the VMS and outsourced solutions businesses.

    本季VMS營收為2,800萬美元,年減41%,季減5%。部門毛利率為60.2%,低於去年同期的66.7%,主要因VMS與外包解決方案(outsourced solutions)業務營收較低。

  • Segment operating margin in the second quarter was 42.1%, a decrease of 200 basis points from the prior year period, driven by the decrease in gross margin, partially offset by reduction of SG&A expense.

    第二季部門營業利益率為42.1%,較去年同期下降200個基點,主要由毛利率下滑所致,部分被SG&A費用降低所抵銷。

  • Segment operating margin increased 280 basis points from the prior quarter, mainly due to lower employee expense. Second quarter consolidated adjusted EBITDA was $94 million, a decrease of 42% year over year and 4% sequentially. Adjusted EBITDA margin for the quarter of 12.7% was above the high end of the guidance range, mainly due to favorable insurance actuarial adjustments and lower employee expenses.

    部門營業利益率較前一季提升280個基點,主要因員工費用較低。第二季合併調整後EBITDA為9,400萬美元,年減42%,季減4%。本季調整後EBITDA利潤率12.7%高於指引區間上緣,主要因保險精算調整有利以及員工費用較低。

  • Year over year adjusted EBITDA margin was down 360 basis points, primarily due to deleveraging on lower revenue while we reduced SG&A expenses to follow the revenue declines sequentially, adjusted EBITDA margin was up 80 basis points driven by the Technology and Workforce Solutions segment and a favorable mix shift.

    年對年調整後EBITDA利潤率下降360個基點,主要因營收下降造成槓桿效益減弱(deleveraging);同時我們下調SG&A費用以因應營收的連續下滑。就季比而言,調整後EBITDA利潤率上升80個基點,受科技與人力解決方案部門帶動及產品組合有利變化(mix shift)所致。

  • Second quarter net income was $16.2 million, down 73% year over year and 6% sequentially. Second quarter GAAP diluted earnings per share was $0.42. Adjusted earnings per share for the quarter was $0.98 compared with $2.38 in the prior-year period and $0.97 in the prior quarter. Days sales outstanding for the quarter was 63 one day lower than the prior quarter and 10 days higher than a year ago, which was our low mark for DSO in 2023.

    第二季淨利為1,620萬美元,年減73%,季減6%。第二季GAAP稀釋每股盈餘為0.42美元。本季調整後每股盈餘為0.98美元,去年同期為2.38美元,前一季為0.97美元。本季應收帳款週轉天數(DSO)為63天,較前一季少1天,較一年前多10天;一年前是我們在2023年的DSO低點。

  • Since the start of 2024, we have reduced DSO by seven days and expect to end the year below 60 days. Operating cash flow for the second quarter was $100 million in capital expenditures were $27 million. We expect CapEx for the year to total $70 million to 75 million.

    自2024年初以來,我們已將DSO降低7天,並預期年底可降至60天以下。第二季營運現金流為1億美元,資本支出為2,700萬美元。我們預期全年資本支出(CapEx)合計為7,000萬至7,500萬美元。

  • As of June 30, we had cash and equivalents of $48 million, long-term debt of $1.2 billion, including a $345 million drawn on our revolving line of credit and a net leverage ratio of 2.6 times to 1 times. During the quarter, we paid off $80 million of revolver debt bringing the year to date paydown $115 million.

    截至6月30日,我們持有現金及約當現金4,800萬美元,長期負債12億美元,其中包含循環信用額度(revolving line of credit)已動用3.45億美元;淨槓桿比率為2.6倍。本季我們償還8,000萬美元循環貸款債務,使年初至今的償還金額達1.15億美元。

  • Moving to third quarter 2024 guidance, we project consolidated revenue to be in a range of $660 million to $680 million, down 20% to 23% from the prior year period. Gross margin is projected to be between 30.7% and 31.2%. Reported SG&A expenses are projected to be 22% to 22.5% of revenue.

    接著談2024年第三季指引:我們預估合併營收介於6.6億至6.8億美元,較去年同期下降20%至23%。毛利率預估介於30.7%至31.2%。揭露的SG&A費用預估為營收的22%至22.5%。

  • Operating margin is expected to be 2.1% to 2.9% and adjusted EBITDA margin is expected to be 10.6% to 11.1%, average diluted shares outstanding are projected to be approximately $38.3 million. Additional third-quarter guidance details can be found in today's earnings release.

    營業利益率預期為2.1%至2.9%,調整後EBITDA利潤率預期為10.6%至11.1%;平均稀釋流通股數預估約為3,830萬股。更多第三季指引細節請參閱今日的財報新聞稿。

  • And now, operator, please open the call for questions.

    接下來,接線員,請開放提問。

  • Operator

    Operator

  • (Operator Instructions) Trevor Romeo, William Blair.

    (接線員指示) Trevor Romeo,William Blair。

  • Trevor Romeo - Analyst

    Trevor Romeo - Analyst

  • Good afternoon. Thanks for taking the questions, team. I think, one, it would just be great if you could provide any details you have on the bill rate and volume assumptions for nurse and allied that are embedded in the Q3 guide. And then thinking to Q4, I think Cary talked about a range of potential outcomes relative to Q3.

    下午好。感謝團隊接受提問。第一個問題:若可以的話,請提供你們在第三季指引中,對護理與醫技(nurse and allied)的計費費率(bill rate)與量(volume)假設所嵌入的任何細節。另外,展望第四季,我想Cary提到相對於第三季可能會有一個結果區間。

  • And Jeff, I kind of always appreciate the look you tend to give on these calls for two quarters ahead. So, any thoughts on how you'd see Q4 shaping up for bill rates and volumes, just based on what you could see at this point would be really helpful.

    Jeff,我也一直很欣賞你在這類電話會議上,通常會提供往後兩季的觀察。所以,就你目前所見,對第四季計費費率與量的走勢有何看法?這會非常有幫助。

  • Jeffrey Knudson - Chief Financial Officer, Treasurer

    Jeffrey Knudson - Chief Financial Officer, Treasurer

  • Yes. Thanks, Trevor. So as it relates to the Q3 guide, we have bill rates down low single digits sequentially from Q2 and volumes down low double digits in Nurse and Allied from Q2 levels. When we think about the fourth quarter, Carrie mentioned the range of scenarios excluding international. So with the impact of Visa retro aggression on the international business, we would expect that business in the fourth quarter to be down $6 million to $8 million sequentially from Q3.

    是的。謝謝你,Trevor。就第三季指引而言,我們預期計費費率相較第二季季減低個位數百分比,而護理與醫技的量相較第二季將季減低雙位數百分比。談到第四季時,Carrie提到在不含國際業務的情況下有一個情境區間。因此,考量簽證追溯性倒退(Visa retrogression)對國際業務的影響,我們預期第四季該業務將較第三季季減600萬至800萬美元。

  • So that's about a 200 basis points drag on the growth within the segment. And so when we look at fill rates and volumes quarter over quarter, again, winter orders will be a big swing factor for us within the quarter where not only those volumes come in, but the start dates within the quarter and then also where the bill rates land.

    這大約會對該部門的成長造成200個基點的拖累。因此,當我們觀察填補率(fill rates)與量的季對季變化時,冬季訂單將是本季的重要擺動因素:不僅取決於這些量何時進來,也取決於在本季內的起始日期,另外還包括計費費率最後落點。

  • So we would see bill rates within those range of outcomes being anywhere from flattish. It may be down slightly in the fourth quarter and then volumes ranging from a low single digit increase to low single digit down on quarter over quarter.

    因此,在這些結果區間內,我們看到計費費率可能介於大致持平。第四季也可能小幅下滑;而量的範圍則可能從季比低個位數成長到季比低個位數下滑。

  • Cary Grace - President, Chief Executive Officer, Director

    Cary Grace - President, Chief Executive Officer, Director

  • And Trevor, we've gotten some indications from clients to accept those orders, but we wouldn't see them until later in the quarter.

    另外,Trevor,我們已從客戶端收到一些接受這些訂單的訊號,但我們可能要到本季較後段才會看到。

  • Trevor Romeo - Analyst

    Trevor Romeo - Analyst

  • Got it. Okay, thank you both. That was helpful.

    了解。好的,謝謝兩位。很有幫助。

  • Operator

    Operator

  • Brian Tanquilut, Jefferies.

    Brian Tanquilut,Jefferies。

  • Randle Reece - Investor Relations

    Randle Reece - Investor Relations

  • Good afternoon, guys. Maybe I'll follow-up on Trevor's question. So if we see orders up 20%, just like you just said plus low single to minus low single in Q4. Maybe help us bridge that, like how and how does the order number translate to a different volume expectation?

    各位下午好。我想我可以接續 Trevor 的問題。所以如果我們看到訂單成長 20%,就像你剛才說的,再加上第四季落在低個位數成長到低個位數下滑。能否幫我們把這之間串起來:也就是訂單數字如何、以及如何把訂單數字轉換成不同的量(volume)預期?

  • And then also how you think about typical seasonality this year? You're seeing plus 20% orders here. I think normally seasonal patterns are even more pronounced than that. So just curious what you're thinking or what you're saying.

    另外,今年你們怎麼看典型的季節性?你們這裡看到訂單增加 20%。我想通常季節性型態會比這更明顯。所以只是好奇你們的想法或你們在說的是什麼。

  • Jeffrey Knudson - Chief Financial Officer, Treasurer

    Jeffrey Knudson - Chief Financial Officer, Treasurer

  • Yes, Brian, on the seasonality, we went back and looked at the couple of years leading up to 2019, and normally, we would have seen demand increase somewhere in the 25% to 30% range versus what we've seen here this year, up 20% and off a lower trough, quite honestly.

    是的,Brian,關於季節性,我們回頭看了 2019 年之前的幾年,通常相較於今年我們在這裡看到的情況,需求會增加約 25% 到 30%;而今年是成長 20%,而且坦白說是從較低的谷底回升。

  • So, yes, the demand trends are improved, but it was off a lower base and not quite back to where we were pre-pandemic. I think when we just think about the volumes within nurse and allied, one thing I would say is, as we look at the monthly sequence within the third quarter, the traveler count is stable July through September, albeit with a lower starting point in July than we were at the end of Q2.

    所以,是的,需求趨勢有改善,但它是從較低的基期起來,還沒有完全回到疫情前的水準。我想當我們看護理與醫療輔助(nurse and allied)的量時,我會說的一點是:就第三季的月度序列來看,旅派人數(traveler count)在 7 月到 9 月是穩定的,儘管 7 月的起點比第二季末要低。

  • So, that's a much-improved trend from where we were in the second quarter, where June was the low point within the quarter. And so, with that demand, I would just say when we're it gets back to what Cary said about some of our MSP clients, we're still seeing reductions in utilization, and we're seeing extension rates at the low end of what would be historically normal from a continuation standpoint, about 500 basis points off the average, but it's within the norm. But at the low end of that range.

    所以,這比我們第二季看到的情況好很多,因為第二季的低點是在 6 月。因此,針對這個需求,我只想說,回到 Cary 提到的部分 MSP 客戶,我們仍看到使用率(utilization)下降,而且我們看到延長率(extension rates)落在歷史上從延續角度來看屬於正常範圍的低端,大約比平均值低 500 個基點,但仍在常態範圍內。只是位於該區間的低端。

  • Randle Reece - Investor Relations

    Randle Reece - Investor Relations

  • Okay, that makes sense. And then maybe, just as I think about SG&A, any discrete items or one-timers in the SG&A line that you would call out and maybe just how you think we should be modeling SG&A going forward.

    好的,這很合理。那再來,當我思考 SG&A 時,SG&A 這一行有沒有任何你們會特別點出的單次性或一次性項目?以及你們認為我們未來應該如何建模(modeling)SG&A?

  • Jeffrey Knudson - Chief Financial Officer, Treasurer

    Jeffrey Knudson - Chief Financial Officer, Treasurer

  • Yes. So, within the second quarter, we had about $7 million of discrete items that added 100 basis points to adjusted EBITDA margin. So, ex those, we would have been at 11.7%, which was 20 basis points above the high end of the guide. About $4 million of that, $7 million related to an actuarial adjustment on professional liability insurance, which we throw up twice a year in Q2 and Q4.

    有的。所以,在第二季,我們有大約 700 萬美元的單次性項目,讓調整後 EBITDA 利潤率增加了 100 個基點。因此,若排除這些,我們會是 11.7%,比指引上緣高 20 個基點。這 700 萬美元中的約 400 萬美元,與專業責任保險(professional liability insurance)的精算調整有關,我們一年會在第二季與第四季各做一次。

  • The remaining $3 million was related to some variable and incentive compensation accruals. We wouldn't expect those to recur in the third quarter, but despite that, we would see adjusted SG&A dollars pretty flattish in the back half to Q3 levels, you know, as reported on adjusted SG&A.

    其餘 300 萬美元與一些變動薪酬與獎勵薪酬(variable and incentive compensation)的應計(accruals)有關。我們不預期這些會在第三季重複發生,但即便如此,我們仍預期調整後 SG&A 的金額在下半年大致會與第三季水準相當平坦,也就是以調整後 SG&A 的口徑來看。

  • Brian Tanquilut - Analyst

    Brian Tanquilut - Analyst

  • Got it. Thank you.

    了解。謝謝。

  • Operator

    Operator

  • Jeff Silber, BMO Capital Markets.

    Jeff Silber,BMO Capital Markets。

  • Jeffrey Silber - Analyst

    Jeffrey Silber - Analyst

  • Thanks so much. And wanted to dig into some of the demand trends that you've been talking about. I know it's tough to gauge, but do you think most of your hospital clients are you comfortable with the mix of permanent and temporary staff? And we think that's going to go lower what it will take to get that moving in the right direction.

    非常感謝。我想深入了解你們一直在談的一些需求趨勢。我知道這很難衡量,但你認為你們的大多數醫院客戶,對於正式員工與臨時員工的組合是否已經感到滿意?以及我們認為這會再下降,還是需要什麼才能讓它朝正確方向改善?

  • Cary Grace - President, Chief Executive Officer, Director

    Cary Grace - President, Chief Executive Officer, Director

  • So Jeff, maybe I'll talk a little bit about what we're seeing from a macro standpoint. So across the board for both of our clients, we're seeing higher patient utilization. And against that, what we've been seeing over the past four to five quarters, it's very strong permanent hiring. They've also seen higher retention rates.

    Jeff,我先從總體(macro)角度談談我們看到的情況。整體而言,對我們兩類客戶來說,我們都看到病患使用量(patient utilization)更高。相對地,在過去四到五個季度,我們看到非常強勁的正式人力招募(permanent hiring)。他們也看到更高的留任率(retention rates)。

  • Now those retention rates were coming off of, you know, unusually low retention rates during COVID. And we've also seen a lot of effort to hire lower paid workers to support some of the clinical roles. But even with all these efforts and they've been very strong, especially around the permanent hiring, you're still seeing open roles, 2.1 times to 1 times from a higher standpoint.

    而這些留任率是從 COVID 期間異常偏低的留任率回升上來的。我們也看到他們投入很多努力去聘用薪資較低的員工,以支援部分臨床職務。但即便做了所有這些努力,而且成效很強,尤其是在正式招募方面,你仍然看到職缺(open roles)偏高,從高位來看大約是 2.1 倍到 1 倍的水準。

  • And so we're seeing still pressure as you increase patient utilization against the workforce that's available. And if you look at the contingent premium for now in the back half of the year getting back and we're in normal ranges of 15% to 20%. And so those sets of dynamics, I think, are making it more interesting from a demand standpoint.

    因此,當病患使用量上升、而可用勞動力供給有限時,我們仍看到壓力。如果你看臨時人力的溢價(contingent premium),今年下半年回到正常區間,大約 15% 到 20%。所以我認為這些動態組合,讓需求面變得更有意思。

  • What we're seeing from clients is even if they have a target of where they want their contingent spend to be, they may have underestimated some of the efforts to permanent hiring or not factored in some of the retention efforts. So we're seeing those factors and play in, I say, particularly over the past quarter or two, where they're coming out.

    我們從客戶端看到的是:即使他們有一個希望臨時人力支出(contingent spend)達到的目標,他們可能低估了正式招募的一些努力,或沒有把某些留任措施的效果納入考量。所以我們看到這些因素在發酵,我會說特別是在過去一兩個季度,這些影響開始顯現。

  • Jeffrey Silber - Analyst

    Jeffrey Silber - Analyst

  • All right, that's helpful. If I could ask a similar question about your own workforce. Are you at the point where you think you've rightsized enough that your workforce can handle the current demand environment? And how quickly can you turn if things start to move in the right direction?

    好的,這很有幫助。如果我可以問一個類似的問題,關於你們自己的員工隊伍。你們是否已經調整到合適規模(rightsized),讓你們的人力可以應付目前的需求環境?如果情況開始往好的方向走,你們能多快轉向(turn)?

  • Cary Grace - President, Chief Executive Officer, Director

    Cary Grace - President, Chief Executive Officer, Director

  • Yes, we feel good about where we are. We've been very conscientious about rightsizing as we saw demand and you know, shakeout in different parts of our business. But we are positioning ourselves both in terms of our workforce and our capabilities to be able to meet rising demand conditions.

    是的,我們對目前的狀態感到滿意。當我們看到需求變化、以及業務不同部分出現洗牌(shakeout)時,我們在調整規模方面一直非常審慎。但我們也在員工配置與能力建置兩方面做好定位,以便能夠因應需求回升的情境。

  • Jeffrey Silber - Analyst

    Jeffrey Silber - Analyst

  • Great. Thanks so much for the color.

    很好。非常感謝你提供的說明。

  • Operator

    Operator

  • A.J. Rice, UBS.

    A.J. Rice,UBS。

  • A.J. Rice - Analyst

    A.J. Rice - Analyst

  • Hi, thanks, Evert everybody. Maybe just following on Jeff's comment about, I guess, carry to some degree of fourth quarter with what you're envisioning with revenue down well, how does that translate into? Do you think we're at a stable point with gross margin from Q3 to Q4? How about SG&A?

    嗨,謝謝,Evert,各位。我想接續 Jeff 的評論,關於你們對第四季某種程度上的看法:在你們預期營收明顯下滑的情況下,這會如何反映到……?你認為從第三季到第四季,毛利率會處於穩定點嗎?那 SG&A 呢?

  • Is that sort of flatten out? Or is there any reason that would step up or down? I think and I'm not looking for necessarily a specific estimate, but directionally, where we're at is we think we're bottoming out here generally?

    會不會大致持平?或者有任何原因會讓它上升或下降?我想——我不一定是在尋求一個具體估計,但就方向性而言,我們目前的位置是否意味著我們大致已經在這裡觸底(bottoming out)了?

  • Jeffrey Knudson - Chief Financial Officer, Treasurer

    Jeffrey Knudson - Chief Financial Officer, Treasurer

  • Yes, I would say, A.J., on the gross margins, both from a nurse and allied standpoint and also from a consolidated standpoint, I think something in the high 30s, you know, 30%, 30.8%, 30.9% to the low 31%, is a reasonable estimate, which is essentially the midpoint of the guide for Q3 and where we were in Q2 that that's reasonable to think about the fourth quarter that same way.

    是的,我會說,A.J.,就毛利率而言,無論是護理與醫療輔助(nurse and allied)層面,或是合併(consolidated)層面,我認為落在 30% 高段,也就是 30.8%、30.9% 到 31% 低段,是一個合理的估計;這基本上就是第三季指引的中點、以及我們第二季所在的水準,因此合理地可以用同樣方式來看第四季。

  • And then from an adjusted SG&A standpoint, dollars being relatively flattish over Q2 levels would also be the right way to think about the fourth quarter.

    然後,從經調整的 SG&A 角度來看,金額相較於第二季水準大致持平,這也是看待第四季的正確方式。

  • A.J. Rice - Analyst

    A.J. Rice - Analyst

  • Okay. That's helpful. Just thinking about the use of cash flow from here on, I guess by our calculation, you ended the quarter at 2.6 times debt to EBITDA. I think you'll be at three or above as you exit the year is paying down debt a priority. Where are you comfortable on that leverage ratio as you go forward?

    好的。這很有幫助。就從現在開始思考現金流的運用,我想按我們的計算,你們在本季末的債務對 EBITDA 倍數為 2.6 倍。我認為你們在年底退出時會到 3 倍或以上;償還債務是否是優先事項?往後你們對這個槓桿比率的舒適區間在哪裡?

  • Jeffrey Knudson - Chief Financial Officer, Treasurer

    Jeffrey Knudson - Chief Financial Officer, Treasurer

  • Yes. Debt paydown has been a priority as we've been gone through the first half of this year. We've paid off $115 million year to date, and that includes $80 million in the second quarter alone, AJ. So we'll continue to prioritize debt paydown with excess free cash flow for the remainder of this year and probably into the early part of '25 as well.

    是的。在今年上半年,我們一直把償還債務作為優先事項。今年迄今我們已償還 1.15 億美元,其中光是第二季就償還了 8,000 萬美元,AJ。因此,今年剩餘時間我們會持續以多餘的自由現金流優先償債,可能也會延續到 2025 年初。

  • A.J. Rice - Analyst

    A.J. Rice - Analyst

  • And how I guess I'm trying to get at what is what leverage ratio would you sort of be back to a balance between potentially acquisitions, buybacks and leverage that wherever you guys feel comfortable and it's sort of at a good point.

    那我想我想問的是,你們認為槓桿比率回到什麼水準時,會在潛在併購、庫藏股回購與槓桿之間重新取得平衡,也就是你們覺得比較舒適、也比較合適的點?

  • Jeffrey Knudson - Chief Financial Officer, Treasurer

    Jeffrey Knudson - Chief Financial Officer, Treasurer

  • We'd want to see it back below [2.5] before we went, do you prioritize debt paydown.

    我們希望看到它回到低於 [2.5],之後我們才會——你問的是是否優先償債。

  • A.J. Rice - Analyst

    A.J. Rice - Analyst

  • Okay. Thanks a lot.

    好的。非常感謝。

  • Operator

    Operator

  • Mark Marcon, Baird.

    Baird 的 Mark Marcon。

  • Mark Marcon - Analyst

    Mark Marcon - Analyst

  • Good afternoon and thanks for taking my questions. Really found the comments on the volumes on helpful. I was wondering, can you talk a little bit about what you're seeing just in terms of the pay rates on what some of the traveling nurses are looking for?

    下午好,謝謝讓我提問。我覺得你們對量的評論非常有幫助。我想請你們談談,就流動護理師(traveling nurses)所期待的薪資水準而言,你們目前看到的是什麼情況?

  • You did mention that the premiums are coming down to 15% to 20% above perm for contingent. And so is that sufficient to to fill demand? That's the first question.

    你確實提到,臨時人力(contingent)相對於正式員工(perm)的溢價正在下降到高出 15% 到 20%。那這樣的水準是否足以滿足需求、填補缺口?這是第一個問題。

  • Cary Grace - President, Chief Executive Officer, Director

    Cary Grace - President, Chief Executive Officer, Director

  • I think historically, if you look at that premium and that has typically been sufficient to fulfill demand. Obviously, you're going to have differences in geography and specialties. And I think, Mark, when you look at one of the things that we look at from a macro standpoint is the premium is off of an increasing permanent wage.

    我認為從歷史來看,如果你看這個溢價水準,通常足以滿足需求。當然,不同地區與不同專科會有差異。而且我想,Mark,從總體角度我們觀察的一點是:這個溢價是建立在持續上升的正式員工薪資之上。

  • And so I think that's going to be one of the dynamic factors that you look at where over the past year and a half, we really had the contingent wages, as at a very high premium coming down. But now as you've gotten into these normalized ranges. It's off of a of a base that has increased.

    因此我認為這會是你要看的動態因素之一:在過去一年半,我們的臨時人力薪資曾處於非常高的溢價,之後一路下滑。但現在當你進入這些正常化區間時,它是建立在一個已經提高的基準之上。

  • Mark Marcon - Analyst

    Mark Marcon - Analyst

  • Great. So it sounds scary like the on the fill rates are in line with what your expectations would be and filling the orders is not an issue. It's still just demand from the clients. Is that correct?

    很好。所以聽起來填補率(fill rates)符合你們的預期,填單並不是問題。仍然只是客戶端的需求問題。是這樣嗎?

  • Cary Grace - President, Chief Executive Officer, Director

    Cary Grace - President, Chief Executive Officer, Director

  • Yes. I'd say largely that I mean, if you have specialties that are hard to sell, they're going to be hard to sell. But if you have orders that are priced at market, you see high fill rates. So it really is about the demand.

    是的。我會說大致如此;如果你有一些很難銷售的專科,那就會很難銷售。但如果你的訂單定價符合市場,你會看到很高的填補率。所以關鍵確實在於需求。

  • Mark Marcon - Analyst

    Mark Marcon - Analyst

  • Okay, great. And then can you just talk a little bit? I mean, obviously, everybody in the entire space is facing the same sort of demand characteristics. It sounds like the bill rates are holding up relatively well.

    好的,很好。接著能否再談一下?我的意思是,顯然整個產業的所有公司都面臨相同的需求特性。聽起來計費率(bill rates)相對維持得不錯。

  • Can you just talk a little bit about competition and what you're seeing on that front and how confident are you in terms of the prognostication that you gave with regards to how you would expect the bill rates to flow through the balance of this year?

    你能否談談競爭情況、你們在這方面看到什麼?以及你們對於先前所給的預測——關於你們預期計費率在今年剩餘期間的走勢——有多大信心?

  • Cary Grace - President, Chief Executive Officer, Director

    Cary Grace - President, Chief Executive Officer, Director

  • Yes, let me talk a little about competition. And then Jeff can talk a little about the transparency we have on bill rates and we have been in a competitive environment. We continue to be in an competitive environment so I don't see that changing in the short and intermediate term.

    好的,我先談談競爭。然後 Jeff 可以談談我們對計費率的透明度。我們一直處於競爭環境中。我們仍將處於競爭環境中,所以我不認為短期到中期會有改變。

  • And so we've seen pressure as everyone in the industry has over the past year. So that's reflected in both what you have seen from a performance standpoint, but also our forecast.

    因此,過去一年我們也像產業內所有公司一樣承受壓力。這反映在你們看到的營運表現上,也反映在我們的預測中。

  • Jeffrey Knudson - Chief Financial Officer, Treasurer

    Jeffrey Knudson - Chief Financial Officer, Treasurer

  • Yes, Mark. And then I would just say on the bill rates for the third quarter, when we look at the bill rates that we have in July for our travelers on assignment and where we're booking future TOA that supports that low-single digit down into the third quarter, and then obviously, seasonally, we'll get some influence on the bill rate from those winter needs orders.

    是的,Mark。至於第三季的計費率,當我們看 7 月份我們派遣中的旅遊護理師(travelers)之計費率,以及我們正在預訂的未來 TOA(任務指派)時,這些都支持第三季計費率呈現低個位數下滑;而且很明顯,季節性因素會讓冬季需求訂單對計費率產生一些影響。

  • And that we believe in a flattish scenario would offset any pressure on bill rates in the non-winter needs orders.

    我們認為在大致持平的情境下,這將抵消非冬季需求訂單對計費率的任何壓力。

  • Mark Marcon - Analyst

    Mark Marcon - Analyst

  • Great. And then on a positive note, you're seeing really nice traction with ShiftWise. You mentioned getting up to 50%. Where do you think that can get to and what would be the implications of that?

    很好。另外一個正面訊息是,你們在 ShiftWise 上看到非常好的動能。你提到已經到 50%。你認為這可以提升到多少?其影響會是什麼?

  • Cary Grace - President, Chief Executive Officer, Director

    Cary Grace - President, Chief Executive Officer, Director

  • Yes. So let me give context for what the 50% is. So we are very happy with how we are doing on ShiftWise Flex. And so our number one goal is to replatform our ShiftWise clients into ShiftWise Flex. So that 50% number is we are over halfway in terms of client spend under management, putting them onto ShiftWise Flex.

    是的。我先說明一下這個 50% 的背景。我們對 ShiftWise Flex 的進展非常滿意。因此,我們的首要目標是把 ShiftWise 客戶重新平台化(replatform)到 ShiftWise Flex。這個 50% 指的是:以我們管理的客戶支出(client spend under management)來看,我們已經完成超過一半的客戶轉移到 ShiftWise Flex。

  • We also started with our first MSP clients, and we expect, as we end this year to have the majority of our VMS clients completed, and we would expect to have made significant progress with our MSP clients. So first, you know, some priority for us is re-platforming existing clients. Second piece, Mark, is building our pipeline, which we saw very healthy progress again, when we look at it from a quarter over quarter basis.

    我們也已經從第一批 MSP 客戶開始,並且預期在今年結束時,我們的大多數 VMS 客戶會完成;同時也預期在 MSP 客戶方面會取得顯著進展。所以第一,你知道的,我們的優先事項之一是把既有客戶重新平台化。第二部分,Mark,是建立我們的管線(pipeline);從季對季來看,我們再次看到非常健康的進展。

  • Mark Marcon - Analyst

    Mark Marcon - Analyst

  • Great. What are the financial implications of that?

    很好。那在財務上的影響是什麼?

  • Cary Grace - President, Chief Executive Officer, Director

    Cary Grace - President, Chief Executive Officer, Director

  • So, if you think about the financial implications, the first one on re-platforming should not be accretive from a revenue standpoint, they're existing clients. We think that there's opportunities, especially because ShiftWise Flex has enhanced capabilities from a technology standpoint for that to be a platform that we can do more with some of those existing clients.

    所以,如果你思考財務影響,第一點是重新平台化在營收面不應該是增益(accretive),因為它們是既有客戶。我們認為仍有機會,特別是因為 ShiftWise Flex 在技術面具備更強的能力,這會是一個平台,讓我們能在部分既有客戶上做更多事情。

  • If you look at our pipeline, that pipeline revenue impact really wouldn't have any impact until 2025 as you started to work down the pipeline and then onboard wins from that pipeline. So, it won't have an impact this year. You should expect it to have more of an impact as you get into the back half of 2025.

    如果你看我們的管線,該管線對營收的影響要到 2025 年才會開始顯現,因為你要開始消化管線,並把管線中的贏單導入上線(onboard)。所以今年不會有影響。你應該預期在 2025 年下半年時影響會更明顯。

  • Mark Marcon - Analyst

    Mark Marcon - Analyst

  • Great. Thanks for the color. Appreciate it.

    很好。謝謝提供這些補充說明。感謝。

  • Operator

    Operator

  • Kevin Fischbeck, Bank of America.

    Kevin Fischbeck,美國銀行。

  • Kevin Fischbeck - Analyst

    Kevin Fischbeck - Analyst

  • Great, thanks. I guess you're the second company to say that the orders are up about 20% since the beginning of Q2, but still talking about stable but below Q2 average revenue, and then Q4 sounds like still also kind of stable-ish, despite the orders going up. So, does that that mean something around, I guess you mentioned that orders are able to be filled if they're at market.

    很好,謝謝。我想你們是第二家提到自第二季初以來訂單大約增加20%的公司,但同時仍在談營收維持穩定、但低於第二季平均水準,然後第四季聽起來也仍然算是相對穩定,儘管訂單在上升。所以,這是否表示某種情況——我想你提到如果訂單是按市價,便能夠被履行。

  • Does that mean that these orders that are coming in are not at market? Or why isn't there a better correlation between 20% and the revenue numbers over the next couple of quarters?

    這是否表示目前進來的這些訂單不是按市價?或者為什麼20%的增幅,和未來幾季的營收數字之間沒有更好的相關性?

  • Cary Grace - President, Chief Executive Officer, Director

    Cary Grace - President, Chief Executive Officer, Director

  • Yes, I'd say two things. One is you always have some mix of orders that are going to be at market rates or below. And so, what you tend to see is for orders that come in that aren't at market, they have very low fill rates, and they tend to age. So that's going to be true.

    是的,我會說有兩點。第一,你總會有一些訂單組合是按市價或低於市價的。因此你通常會看到,對於那些不是按市價進來的訂單,它們的成交/填補率非常低,而且往往會被拖久、變得陳舊。所以這會是事實。

  • As you see increased demand, you're going to have some of those orders that are not going to be at market. And you tend to see them age. In terms of when you look at what we're seeing overall from the demand increases and open orders that we've seen since the beginning of April, and it's a little bit of what Jeff had talked about earlier.

    當你看到需求增加時,就會有一部分訂單不會是按市價。而你通常會看到它們被拖久。至於你看我們自四月初以來整體看到的需求增加與未結訂單,這也有點呼應Jeff先前談到的。

  • We're also seeing for some large clients where they have reduced utilization. We've seen this, a lot in our extension rate. And so that's the piece, Kevin, where we're seeing, promising signs around the demand, but we still have some stabilization that we are seeing with some of our clients.

    我們也看到一些大型客戶的使用率降低。我們在續約率上看到很多這種情況。所以這一塊,Kevin,我們在需求面看到令人鼓舞的跡象,但同時也看到部分客戶仍在趨於穩定。

  • Kevin Fischbeck - Analyst

    Kevin Fischbeck - Analyst

  • Okay. And then I guess the winter orders because I think historically you'd have a little bit of color at this point. It sounds like it sounds like it's kind of been pushed back a little bit as far as when those quarters come in. Is that is there an implication for that? I guess in the past, if they come in a little bit later, does that it doesn't mean that the orders are going to be lower or does it or does that not necessarily follow through?

    了解。然後我想問冬季訂單,因為我認為歷史上到這個時間點你們通常會提供一些補充說明。聽起來這次在那些訂單進來的時間點上有點往後延。這有什麼含意嗎?我想過去如果進來得晚一些,是否不代表訂單量會比較低,還是說不一定會有這樣的連動?

  • Jeffrey Knudson - Chief Financial Officer, Treasurer

    Jeffrey Knudson - Chief Financial Officer, Treasurer

  • Yes. I think Kevin White from a timing standpoint, we're expecting it to look like last year, I don't know that coming in later signals anything in terms of volume. But what we did see last year versus pre pandemic was a shift where more of those Q4 starts were in the mid to late November timeframe, which was a couple of weeks later than normal, what we had seen 2019 and prior.

    是的。我想就時點而言,Kevin White,我們預期會和去年類似;我不認為進來得較晚在量的方面代表什麼。但我們去年相較於疫情前確實看到一個轉變:更多第四季開始的案子落在11月中下旬,這比我們在2019年及更早看到的正常情況晚了幾週。

  • Kevin Fischbeck - Analyst

    Kevin Fischbeck - Analyst

  • And is that a new normal? Does that mean that hospitals are just waiting a little bit longer to use temp staffing and that's just the way it's going to be but could you is there if any that they need it and eventually?

    那這會是新的常態嗎?這是否表示醫院只是再多等一點才使用臨時人力,這就是未來的方式——但如果他們需要,最終還是會用上?

  • Jeffrey Knudson - Chief Financial Officer, Treasurer

    Jeffrey Knudson - Chief Financial Officer, Treasurer

  • Yes, it could look, I don't know if it's a new normal, it could look like last year. But we also then did see some of the benefit into that, into the first quarter. I would say the total duration of those orders was probably on par with what we had seen in 2019. They started later, but then maybe went a little longer into the first quarter.

    是的,它可能會看起來像去年;我不確定這是不是新的常態。但我們也確實看到其中一些效益延伸到第一季。我會說這些訂單的總期間大概與我們在2019年看到的相當。它們開始得較晚,但可能會稍微延長到第一季。

  • Cary Grace - President, Chief Executive Officer, Director

    Cary Grace - President, Chief Executive Officer, Director

  • And Kevin, the other part that I'd say, and again, I don't know that we can call this the new normal, but we're seeing some of these delays just across the Board. It's not just with winter orders. So, I don't know that I would read anything into that.

    Kevin,另外我想補充的是——同樣地,我不確定我們能否稱之為新的常態——我們看到這些延遲其實是全面性的。不只是冬季訂單。所以我不會對此做過多解讀。

  • Kevin Fischbeck - Analyst

    Kevin Fischbeck - Analyst

  • Okay. And then I guess last question on the SG&A side, you spiked out to $7 million. Is there anything else there because I guess in the press release there's commentary about lower compensation costs and with lower demand, is that something that we should be on the lookout for?

    了解。最後一個問題關於SG&A,你們跳升到700萬美元。那裡還有其他因素嗎?因為我想新聞稿裡有提到薪酬成本較低、以及需求較低;這是我們需要留意的事情嗎?

  • If demand does improve, will there be pressure on the SG&A next year, or is this a good base to be thinking about SG&A as a percentage of revenue going forward?

    如果需求改善,明年SG&A會有壓力嗎?還是說,這是一個不錯的基準,可以用來思考未來SG&A占營收比重?

  • Jeffrey Knudson - Chief Financial Officer, Treasurer

    Jeffrey Knudson - Chief Financial Officer, Treasurer

  • I think probably the biggest thing for next year from a base standpoint is similar to last year's. We would have a reset on incentive and variable compensation, just again, given the year that we've had in 2024, and then you would have your normal merit and other inflationary type adjustments that would hit in '25 that aren't in that base right now.

    我認為明年就基準而言,最大的因素大概會和去年類似。我們會在獎金與變動薪酬上做一次重設,主要是考量我們2024年的表現,然後在2025年會有正常的調薪以及其他通膨型調整,而這些目前的基準尚未反映。

  • Kevin Fischbeck - Analyst

    Kevin Fischbeck - Analyst

  • Is there a way to size that?

    有辦法量化那個規模嗎?

  • Jeffrey Knudson - Chief Financial Officer, Treasurer

    Jeffrey Knudson - Chief Financial Officer, Treasurer

  • On the incentive and variable side, you can think about that probably in the $3 million to $4 million per quarter range.

    就獎金與變動薪酬而言,你可以把它想成每季大約300萬到400萬美元的範圍。

  • Kevin Fischbeck - Analyst

    Kevin Fischbeck - Analyst

  • Perfect. Thanks.

    太好了。謝謝。

  • Operator

    Operator

  • Tobey Sommer, Truist Securities.

    Tobey Sommer,Truist Securities。

  • Tobey Sommer - Analyst

    Tobey Sommer - Analyst

  • Thank you. I was wondering if you could talk about how you feel you're doing with all the internal idiosyncratic changes, you could make tore to address the marketplace as demand has fallen now for a protracted period of time on you consolidated some brands, if you're trying to cross-sell more services. Is my understanding how do you feel like like you're prosecuting the changes you can control?

    謝謝。我想請你談談,在需求下滑且已持續一段較長時間的情況下,你們對於內部那些具公司特定性的變革做得如何——例如你們整併了一些品牌、是否嘗試交叉銷售更多服務。我的理解是:你們覺得自己在推動那些你們可控的改變方面做得如何?

  • Cary Grace - President, Chief Executive Officer, Director

    Cary Grace - President, Chief Executive Officer, Director

  • Yes. So, if you think about some of the core pieces, Tobey, that we've talked about, that we are changing our model to ensure that we are aligning ourselves to a bigger market TAM, you know, the first is our go-to-market strategy. So, we had been for a number of years focused on a very important, but, you know, a minority part of the market in MSPs. So, we have aligned ourselves to all segments of the market, and we're seeing progress on that.

    是的。Tobey,如果你回想我們談過的一些核心重點,我們正在改變我們的模式,以確保我們能對齊更大的市場TAM(可服務總市場);第一個就是我們的市場進入策略(go-to-market strategy)。過去多年我們聚焦在MSP這個市場中非常重要、但占比相對較小的一部分。因此我們已將自身對齊到市場的所有細分領域,並且看到進展。

  • So, if you look at Q1 to Q2, we saw healthy increases in the positions filled in third-party and direct relationships. So, we had a number of initiatives that were aimed against that including operational automation. We made significant progress in our speed to fill so there were operational and technology enhancements behind being able to achieve some of those increases.

    所以,如果你看第一季到第二季,我們在第三方與直接合作關係中,已填補職缺數都有健康的成長。我們針對此推出了多項措施,包括營運自動化。我們在「填補速度」方面取得顯著進展;因此在營運與技術上都有強化,支撐我們達成其中一些增長。

  • From a brand standpoint, we are completed with the brand integration, and so we've consolidated the staffing brands. We're keeping B.E. Smith, which serves a very different audience, separate, and you will see a reinvigoration of that brand. So, we're seeing strong outcomes in our overall brand testing. We're seeing over 250,000 clinicians who are now on our Passport App. So, we're seeing progress on our go-to-market strategy to align ourselves against the entirety of the market.

    就品牌而言,我們已完成品牌整合,因此我們已整併人力派遣相關品牌。我們會保留B.E. Smith,因為它服務的是非常不同的受眾,會維持獨立,你也會看到該品牌重新振興。因此我們在整體品牌測試上看到強勁成果。我們看到目前已有超過25萬名臨床人員使用我們的Passport App。所以我們在市場進入策略上、讓自己對齊整個市場的方向,正持續看到進展。

  • On our digitization of the company, again, and I know I talked about a number of these initiatives in my opening comments, but we've been very focused on how we align and innovate with our clients to help them build sustainable workforces. So, a lot of that's what we've done with ShiftWise Flex and the data and analytics and the market data, as well as AI-enabled workforce planning and scheduling.

    關於我們公司的數位化,再次說明一下;我知道我在開場致詞中談到了其中不少項目,但我們一直非常專注於如何與客戶對齊並共同創新,協助他們打造可持續的人力隊伍。因此,我們在 ShiftWise Flex、資料與分析、市場數據,以及 AI 驅動的人力規劃與排班方面做了很多工作。

  • Our scheduling platform was rated number one in class for the second year in a row. So, we've done a lot of work around ensuring that we have a tech-enabled set of services to help clients with where they want to go. And I'd say the same thing for clinicians with the enhancements that we've done on Passport and connecting our clinician app to really important client technology so that we can connect clinicians to clients.

    我們的排班平台連續第二年被評為同級最佳、排名第一。因此,我們在確保具備一套以科技賦能的服務方面投入了大量工作,來協助客戶達成他們想要前往的方向。對臨床人員也是同樣的情況:我們對 Passport 所做的強化,以及將我們的臨床人員 App 連接到非常重要的客戶端技術,讓我們能把臨床人員與客戶連結起來。

  • Tobey Sommer - Analyst

    Tobey Sommer - Analyst

  • At this juncture, how do you think it's influencing market share or wallet share how we choose to think about it.

    在這個時間點,你認為這對市占率或錢包份額(我們選擇用哪種角度來看)有什麼影響?

  • Cary Grace - President, Chief Executive Officer, Director

    Cary Grace - President, Chief Executive Officer, Director

  • Yes. So from a market share standpoint, on what we experienced going, you know, focused on MSP clients during a significant period of growth during COVID that was not favorable to us. And if we look at this year versus last year in terms of net wins and losses, we came out of last year where we were in a net loss position.

    是的。就市占率而言,回顧我們在 COVID 期間一段顯著成長期內、聚焦於 MSP 客戶的經驗,那對我們並不有利。如果我們以今年對比去年來看淨新增與淨流失,我們在去年是處於淨流失的狀態。

  • We are and expect to be net neutral on clients from this year and so that is progress. Obviously, we want to translate and get to a position where we're getting into net growth.

    我們今年在客戶數方面目前是、且預期將會是淨持平,因此這是一種進展。當然,我們希望能把這轉化為淨成長的局面。

  • Tobey Sommer - Analyst

    Tobey Sommer - Analyst

  • And what are the signs telling you with respect to your international business and Visa Direct progression? Are there any updates that you've either seen that indicate when you could see a turn or dates out in the future that you're anticipating some sort of an update? Thanks.

    那麼,關於你們的國際業務以及 Visa Direct 的進展,有哪些跡象在告訴你們什麼?你們是否看到任何更新,能指示何時可能出現轉折,或是未來有哪些日期你們預期會有某種更新?謝謝。

  • Cary Grace - President, Chief Executive Officer, Director

    Cary Grace - President, Chief Executive Officer, Director

  • And there is a there is a Board team released today and I would say it was largely neutral on what we're looking for is the October bulletin, which typically comes out in late September, that will set the visas for next year. And so we should have a better idea. And as that bulletin comes out about what we would expect in terms of leases for the future.

    今天確實發布了一份 Board 團隊的公告;我會說它大致上是中性。就我們在尋找的部分而言,是通常在九月底發布的 10 月公告(bulletin),它將設定明年的簽證名額。因此,我們應該會有更清楚的概念。而當該公告發布時,我們也會更了解對未來簽證配額的預期。

  • Our strategy on the international side is we are very intentionally on keeping our pipeline very up-to-date. So as those Visa numbers, we get clarified and get awarded that we have all of our commissions in place and ready to go.

    我們在國際端的策略是:我們非常有意識地讓我們的管線保持最新。因此,當那些簽證名額被釐清並獲得核發時,我們所有的委託安排都已就位、隨時可以啟動。

  • Tobey Sommer - Analyst

    Tobey Sommer - Analyst

  • Thank you.

    謝謝。

  • Operator

    Operator

  • Bill Sutherland, Benchmark Company.

    Benchmark Company 的 Bill Sutherland。

  • Bill Sutherland - Analyst

    Bill Sutherland - Analyst

  • Hi, everybody. I was just wondering at this point; I think we've checked all the questions here. Jeff, on in locum, the MSDR acquisition, did you call out the impact in 2Q and what's in it? What's in the 3Q guidance?

    大家好。我只是想問一下,在這個時間點;我想我們已經把這裡所有問題都問完了。Jeff,關於 locum(代班醫師)業務,MSDR 併購案,你有提到它在第二季的影響以及包含了什麼嗎?第三季指引裡又包含了什麼?

  • Jeffrey Knudson - Chief Financial Officer, Treasurer

    Jeffrey Knudson - Chief Financial Officer, Treasurer

  • Yes, it was $34 million of revenue in the second quarter mill, and we would expect that to be maybe down modestly sequentially into Q3.

    有的,第二季是 3,400 萬美元的營收,我們預期第三季可能會較第二季小幅季減。

  • Bill Sutherland - Analyst

    Bill Sutherland - Analyst

  • Is that seasonality?

    那是季節性因素嗎?

  • Jeffrey Knudson - Chief Financial Officer, Treasurer

    Jeffrey Knudson - Chief Financial Officer, Treasurer

  • No, I think that gets to what Cary was talking about earlier with what we're seeing probably more broadly in locums, where we're seeing delays in client decision making and just in lower extensions, and probably more of a focus on the cost of locums. Demand is still healthy, but it is down from the beginning of the year, and it's certainly down year-over-year.

    不是。我認為這回到 Cary 先前談到的、我們在 locums 市場更廣泛看到的情況:客戶決策出現延遲、續約(延長)比例較低,且可能更聚焦於 locums 的成本。需求仍然健康,但相較年初已經下降,而且同比也明顯下滑。

  • Bill Sutherland - Analyst

    Bill Sutherland - Analyst

  • And what I was sort of taking away from earlier comments is that the bill pay spread in the the Travelers is just getting kind of back to something it's normal, but that's what's weighing on the spread. Gross margin is lodging and other costs related to one cannot accomplish expenses. Is that on that is that what you guys are saying?

    我從先前的評論中帶走的重點是:Travelers(旅派人員)的帳單與薪資價差(bill-pay spread)只是回到比較正常的水準,但這正是壓抑價差的因素。毛利率方面則是住宿與其他與一次性安置相關的成本。你們的意思是這樣嗎?

  • Jeffrey Knudson - Chief Financial Officer, Treasurer

    Jeffrey Knudson - Chief Financial Officer, Treasurer

  • Yes, that's accurate. When we think about Nurse and Allied gross margins in the second quarter, all other elements of the bill pay spread actually improved slightly over Q1 levels and the downdraft came from the housing and the per diems as well as we had a favorable worker's comp adjustment in the first quarter that didn't repeat in Q2 within Nurse and Allied.

    是的,這樣理解是正確的。當我們看第二季護理與醫療輔助(Nurse and Allied)的毛利率時,帳單與薪資價差的其他所有要素其實相較第一季都略有改善;下滑主要來自住房與日支費(per diems)。此外,我們在第一季於護理與醫療輔助中有一項有利的工傷保險(worker's comp)調整,但第二季沒有重複出現。

  • Bill Sutherland - Analyst

    Bill Sutherland - Analyst

  • Okay. And then just zooming out a little bit, Tom, kind of curious about the marketplace's impact on on your just competitively in the past. They haven't I don't think I made it. It's a big difference in how you do, but curious how you have what looks like today. Thanks.

    好的。然後把視角拉遠一點,Tom,我有點好奇市場平台(marketplace)對你們競爭面的影響。過去它們——我不覺得我說得很到位——在你們表現上似乎沒有造成很大的差異,但我想了解你們今天看到的情況如何。

  • Cary Grace - President, Chief Executive Officer, Director

    Cary Grace - President, Chief Executive Officer, Director

  • What marketplace, Bill?

    Bill,你指的是哪一種 marketplace?

  • Bill Sutherland - Analyst

    Bill Sutherland - Analyst

  • The marketplaces that are, designed to be very automated as far as building positions.

    那些 marketplace,設計上在建立職缺方面非常自動化的那種。

  • Cary Grace - President, Chief Executive Officer, Director

    Cary Grace - President, Chief Executive Officer, Director

  • Got it. I think what we've seen like particularly over in the past six quarters, is that when you look at the supply demand equation, it's actually been the premium spin on, you know, who has access to the demand.

    了解。我認為我們看到的情況是,特別是在過去六個季度,當你看供需方程式時,真正的溢價其實在於——你知道——誰能取得需求端。

  • And so, the marketplaces tend to be a conduit for supply, but they're not always connected in as directly to the demand side as you would see vendor-neutral, direct MSP relationships. So, they obviously are out there, I think but we haven't seen them be as much of a factor in this lower demand environment

    因此,marketplace 往往是供給端的管道,但它們不一定像供應商中立(vendor-neutral)、直接的 MSP 關係那樣,能如此直接地連到需求端。所以,它們顯然存在;但在這個需求較低的環境中,我們沒有看到它們成為那麼重要的因素。

  • Bill Sutherland - Analyst

    Bill Sutherland - Analyst

  • Makes sense. Okay. Thanks, everybody.

    了解。好的。謝謝大家。

  • Operator

    Operator

  • Thank you. This does conclude today's Q&A session. I would like to go ahead and turn the call back over to Cary for closing remarks. Please go ahead.

    謝謝。今天的問答環節到此結束。我想把電話會議交回給 Cary 做結語。請開始。

  • Cary Grace - President, Chief Executive Officer, Director

    Cary Grace - President, Chief Executive Officer, Director

  • Thank you all for your continued interest in AMN. We look forward to continuing to update you on our important mission of empowering the future of care.

    感謝各位持續關注 AMN。我們期待持續向各位更新我們的重要使命:賦能照護的未來。

  • Operator

    Operator

  • Thank you. This concludes today's meeting. You may all disconnect.

    謝謝。今天的會議到此結束。各位可以掛線。